Making Motion: TeleCommunication Systems (NASDAQ:TSYS), Memorial Production Partners LP (NASDAQ:MEMP), GlycoMimetics (NASDAQ:GLYC)

Yamana Gold, Inc. (NYSE:AUY) shares decreased -7.74% in last trading session and ended the day at $1.55. AUY Gross Margin is 40.50% and its has a return on assets of -13.50%. Yamana Gold, Inc. (NYSE:AUY) quarterly performance is -38.49%.

Yamana Gold, Inc. (NYSE:AUY) provides full year preliminary production and cost estimates for 2015, as well as 2016, 2017 and 2018 production, and 2016 cost guidance. Preliminary estimates for by-product cash costs and AISC for the fourth quarter are approximately $540 and $760 per ounce of gold respectively.

Ampio Pharmaceuticals, Inc. (NYSEMKT:AMPE) ended the last trading day at $2.13. Company weekly volatility is calculated as 10.17% and price to cash ratio as 3.13. Ampio Pharmaceuticals, Inc. (NYSEMKT:AMPE) showed a weekly performance of -15.81%.

On 11 January, Ampio Pharmaceuticals, Inc. (NYSEMKT:AMPE) announced that the Abstract titled: “Potential Beneficial Effect of Low Dose Danazol in Combination With Renin Angiotensin System Inhibitors in Diabetic Macular Edema: a 12-week Multicenter Double-Blind Randomized Controlled Trial” was accepted by the World Ophthalmology Conference (WOC 2016) for presentation at the Late Breaking News Session.

On 15 January, TeleCommunication Systems Inc. (NASDAQ:TSYS) shares decreased -0.10% and was closed at $4.95. TSYS EPS growth in last 5 year was -15.50%. TeleCommunication Systems Inc. (NASDAQ:TSYS) year to date (YTD) performance is -0.30%.

On 7 January, TeleCommunication Systems Inc. (NASDAQ:TSYS) announced that the company has expanded its presence in the Middle East by adding two of the largest mobile network operators in the region to its customer portfolio.

Memorial Production Partners LP (NASDAQ:MEMP) shares decreased -7.66% in last trading session and ended the day at $1.93. MEMP Gross Margin is 56.70% and its has a return on assets of -10.20%. Memorial Production Partners LP (NASDAQ:MEMP) quarterly performance is -68.10%.

GlycoMimetics, Inc. (NASDAQ:GLYC) caters to the Healthcare space. It has a net profit margin of -56.50% and weekly performance is -17.73%. On the last day of trading company shares ended up at $4.27. GlycoMimetics, Inc. (NASDAQ:GLYC) distance from 50-day simple moving average (SMA50) is -4.76%.

GlycoMimetics Inc (NASDAQ:GLYC) was downgraded by Zacks Investment Research from a “hold” rating to a “sell” rating in a research note issued to investors on Tuesday, AnalystRatings.Net reports.